Back to Results
First PageMeta Content
Organic chemistry / Drug rehabilitation / Drug addiction / Drug control law / Drug test / Employment / Methadone / Saliva testing / Center for Substance Abuse Treatment / Medicine / Chemistry / Medical tests


Dear Colleague Letter, July 18, 2003
Add to Reading List

Document Date: 2013-06-28 13:12:02

Open Document

File Size: 516,75 KB

Share Result on Facebook

City

North Bethesda / Seattle / Baltimore / /

Company

RTI International / Walsh Group / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / /

Facility

Rockwall II Building / Albert Einstein Medical College / /

IndustryTerm

non-standard test protocols / treatment for a chronic illness / /

MedicalCondition

least eight random drug abuse / chronic illness / opiate addiction / /

Organization

Center for Substance Abuse Treatment / CSAT National Advisory Council / FASAM Center / Subcommittee on Oral Fluid Testing / Albert Einstein Medical College / National Advisory Council / U.S. Food and Drug Administration / Division of Pharmacologic Therapies / CSAT National Advisory Council Subcommittee on Oral Fluid Testing / CSAT’s National Advisory Council / U.S. Securities and Exchange Commission / DEPARTMENT OF HEALTH / Substance Abuse and Mental Health Services Administration / State Methadone Authority / /

Person

Donna Bush / Richard Suchinsky / George Yacoubian / Alan Trachtenbcrg / Ira Marion / Louis Baxter / Bob Lubran / Arlene Stanton / Edward Cone / Ron Jackson / Pamela Jumper Thurman / Eric Wish / Todd Rosendale / Bob Stephenson / Nick Reuter / Alan Trachtenberg / Mark Parrino / /

/

Position

Exec. / Medical Director / physician / Chair / /

Product

OF / /

ProvinceOrState

Texas / Rhode / Rhode Island / Maryland / /

Technology

testing protocols / two relevant Treatment Improvement Protocols / test protocols / /

SocialTag